Latest debt-to-equity ratio
Allogene Therapeutics Debt-to-equity ratio
Direct answer
Allogene Therapeutics's debt-to-equity ratio is 18.11%.
The verified market snapshot reports 18.11%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 12, 2026.
Get free Allogene Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 18.11%
Explore related company data
View Allogene Therapeutics's market capitalizationView Allogene Therapeutics's price-to-book ratioView Allogene Therapeutics's return on equityView Allogene Therapeutics's dividend yieldView Allogene Therapeutics's 52-week price rangeView Allogene Therapeutics's profit marginView all Allogene Therapeutics key metricsReturn to Allogene Therapeutics profile